AI Assistant
Blog
Pricing
Log In
Sign Up
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.